The carbohydrate-based drug industry

Nature Biotechnology

Volumn 15, Issue 5, 1997, Pages 479-480

  Persidis, Aris ^a  

^a Upstate Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE;

ARTICLE; BIOTECHNOLOGY; CHEMISTRY; DRUG DESIGN; DRUG INDUSTRY; DRUG THERAPY; HUMAN;

BIOTECHNOLOGY; CARBOHYDRATES; DRUG DESIGN; DRUG INDUSTRY; DRUG THERAPY; HUMANS;

EID: 0031135759     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0597-479     Document Type: Article

References (10)

1. Dwek, R.A. 1996. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 96:683-720.
2. Frechet, J.M. and Schuerch, C. 1971. Solid-phase trisaccharide synthesis. J. Am. Chem. Soc. 93:492-496.
3. Bednarski, M. and Simon, E.S. (eds.). 1991. Enzymes in Carbohydrate Synthesis, ACS Series 446. American Chemical Society, Washington, DC.
4. Borman, S. 1994. Chemical-enzymatic technique used to make carbohydrates, glycopeptides. Chem. Eng. News 7237-39.
5. BioVista Industry Review & Company Database: Carbohydrate Therapeutics-1997 Edition. ASSETT assett@netor.gr
6. Boons, G-T. 1996. Synthetic oligosaccharides: Recent advances. Drug Dev. Today. 1:331-342.
7. Persidis, A. 1995. Enabling technologies and the business of science. Bio/Technology 13:1172-1176.
8. These companies are Alpha- Beta Technology, Biomira, Cytel, Glycomed, Ligand Pharmaceuticals, Martek, Neose Technologies, and Oxford GlycoSciences.
9. Persidis, A. 1997. Industry trends: Combinatorial chemistry. Nature Biotechnology 15:391-393.
10. Rouhi, M. 1996. Carbohydrates combinatorially. Chem. Eng. News 74:4.